LeGrand v. Abbott Laboratories
This text of LeGrand v. Abbott Laboratories (LeGrand v. Abbott Laboratories) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 CONDALISA LEGRAND, Case No. 22-cv-05815-TSH
8 Plaintiff, DISCOVERY ORDER 9 v. Re: Dkt. No. 91 10 ABBOTT LABORATORIES, 11 Defendant.
12 13 Plaintiff moves to compel 54 documents responsive to her amended request for production 14 40 that Abbott has withheld based on the First Amendment privilege. The withheld documents are 15 communications between Abbott and four industry groups and their members regarding the 16 groups’ (1) draft comments on, and strategy and potential legal arguments about, an FDA 17 proposed product labeling rule, and (2) emails and draft documents reflecting the formulation of 18 trade association strategy regarding pending or proposed regulations, legislation, draft FDA 19 guidance, and proposed international guidelines. See ECF No. 91-9. 20 Despite Abbott’s belated assertion of a First Amendment privilege, the Court declines to 21 find a waiver of this constitutional privilege. “[T]here is case law finding ‘that where a 22 constitutional privilege is involved a trial court possesses the discretion not to find waiver.’” 23 Apple Inc. v. Match Group, Inc., 2021 WL 3727067, *6 (N.D. Cal. Aug. 19, 2021) (quoting In re 24 DG Acquisition Corp., 151 F.3d 75, 81 (2d Cir. 1998)). “‘This is particularly true . . . when the 25 alleged waiver is accomplished by inaction rather than action.’” Id. (quoting same). 26 Abbott has made a prima facie case that producing these communications will chill 27 associational rights. See Perry v. Schwarzenegger, 591 F.3d 1147, 1163 (9th Cir. 2010). The 1 to establish this prima facie case because it is common sense that forcing Abbott to produce these 2 materials will chill the willingness of members of these industry groups to have candid 3 communications with each other about these subjects. And while it is true that commercial speech 4 is entitled to less protection than political, religious, or literary speech, see In re Anonymous 5 Online Speakers, 661 F.3d 1168, 1177 (9th Cir. 2011), it is still entitled to some protection, and 6 the First Amendment “applies to trade associations as well.” In re Recalled Abbott Infant 7 Formula Products Liability Litig., 2024 WL 36982, *1 (N.D. Ill. Jan. 3, 2024).1 8 Abbott “having made a prima facie showing of infringement, the evidentiary burden shifts 9 to the plaintiff[] to demonstrate a sufficient need for the discovery to counterbalance that 10 infringement” of First Amendment rights. Perry, 591 F.3d at 1164. Plaintiff does not demonstrate 11 that need. Plaintiff argues that the communications between the industry group members leading 12 up to the groups’ final public comments may reflect the members’ true beliefs and understandings 13 about the healthfulness of added sugar. While that may be true, it doesn’t demonstrate a need for 14 this discovery. It is unlikely that Abbott or any other company discloses information about added 15 sugar in communications external to the company that it is not also contained, likely in greater 16 detail, in internal documents that would not implicate First Amendment rights. Think about it: 17 For an employee at one of these companies to send an external email to other industry group 18 members stating the company’s views about the effects of added sugar, that information had to 19 come from somewhere. Producing the associational communications would reveal the groups’ 20 strategy concerns and objectives and provide insight into their lobbying efforts – thus implicating 21 First Amendment concerns – but it is not a particularly good way to find out what is known to 22 these companies about the effects of added sugar and whether food products with added sugar can 23 be considered healthy. Internal documents that do not implicate First Amendment concerns are a 24 1 Plaintiff argues that Abbott’s withdrawal of its claim of First Amendment privilege over 16 25 communications on a previous version of its privilege log (ECF No. 91-7) shows that disclosure of these communications is not generally problematic, with the suggestion that Abbott is selectively 26 claiming privilege over the remaining documents because their content is damaging. However, at the hearing both sides agreed those 16 documents were non-substantive (primarily they were 27 meeting invites), and that Abbott has not produced any substantive communications with these 1 better source for that information. 2 Accordingly, Abbott’s claim of First Amendment privilege is SUSTAINED, and 3 || Plaintiffs motion to compel is DENIED. 4 IT IS SO ORDERED. 5 6 Dated: October 9, 2024 7 A —/ \ - l.. f _ THOMAS S. HIXSON 8 United States Magistrate Judge 9 10 11 a 12
15 16
= 17
Z 18 19 20 21 22 23 24 25 26 27 28
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
LeGrand v. Abbott Laboratories, Counsel Stack Legal Research, https://law.counselstack.com/opinion/legrand-v-abbott-laboratories-cand-2024.